- Home
- FATE vs FTLF Comparison
FATE vs FTLF Comparison
Compare FATE & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | FTLF |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 154.6M |
| IPO Year | 2013 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FATE | FTLF |
|---|---|---|
| Price | $1.13 | $13.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $4.10 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.5M | 13.5K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | $6,646,000.00 | ★ $21,744,000.00 |
| Revenue This Year | N/A | $32.74 |
| Revenue Next Year | $1.05 | $50.36 |
| P/E Ratio | ★ N/A | $30.57 |
| Revenue Growth | N/A | ★ 11.52 |
| 52 Week Low | $0.66 | $9.83 |
| 52 Week High | $1.94 | $20.98 |
Technical Indicators
Market Signals| Indicator | FATE | FTLF |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 31.18 |
| Support Level | $0.96 | $13.42 |
| Resistance Level | $1.16 | $15.31 |
| Average True Range (ATR) | 0.13 | 0.42 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 4.27 | 3.77 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.